Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer PatientsMaeda, N. ; Yoshimura, K. ; Yamamoto, S. ; Kuramasu, A. ; Inoue, M. ; Suzuki, N. ; Watanabe, Y. ; Maeda, Y. ; Kamei, R. ; Tsunedomi, R. ; Shindo, Y. ; Inui, M. ; Tamada, K. ; Yoshino, S. ; Hazama, S. ; Oka, M.Annals of surgical oncology, 2014-12, Vol.21 (Suppl 4), p.546-554 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cellsUENO, K ; HAZAMA, S ; MITOMORI, S ; NISHIOKA, M ; SUEHIRO, Y ; HIRATA, H ; OKA, M ; IMAI, K ; DAHIYA, R ; HINODA, YBritish journal of cancer, 2009-10, Vol.101 (8), p.1374-1381 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Brain-Derived Neurotrophic Factor Regulates Cholesterol Metabolism for Synapse DevelopmentSuzuki, Shingo ; Kiyosue, Kazuyuki ; Hazama, Shunsuke ; Ogura, Akihiko ; Kashihara, Megumi ; Hara, Tomoko ; Koshimizu, Hisatsugu ; Kojima, MasamiThe Journal of neuroscience, 2007-06, Vol.27 (24), p.6417-6427 [Periódico revisado por pares]United States: Soc NeuroscienceTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Aortic valve replacement in small patientsHisata, Y. ; Yokose, S. ; Hazama, S. ; Matsumaru, I. ; Eishi, K.Asian journal of surgery, 2018-11, Vol.41 (6), p.578-584 [Periódico revisado por pares]China: Elsevier Taiwan LLCTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A128/6 PolymorphismsOkuyama, Y. ; Hazama, S. ; Nozawa, H. ; Kobayashi, M. ; Takahashi, K. ; Fujikawa, K. ; Kato, T. ; Nagata, N. ; Kimura, H. ; Oba, K. ; Sakamoto, J. ; Mishima, H.Japanese journal of clinical oncology, 2011-04, Vol.41 (4), p.477-482 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
P-157A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2)Iwamoto, S ; Hazama, S ; Kin, H ; Takemoto, H ; Kobayashi, K ; Takahashi, Y ; Kobayashi, M ; Maeda, H ; Nagata, N ; Oba, K ; Sakamoto, J ; Mishima, HAnnals of oncology, 2016-06, Vol.27 (suppl_2), p.ii46-ii46 [Periódico revisado por pares]Oxford University PressTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
P-087A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancerYoshino, S ; Nishimura, T ; Sakata, K ; Yoshida, S ; Furuya, T ; Yamamoto, T ; Kawaoka, T ; Shimizu, R ; Sato, T ; Matoba, K ; Morioka, H ; Iida, M ; Suzuki, N ; Takeda, S ; Ueno, T ; Hazama, S ; Nagano, HAnnals of oncology, 2016-06, Vol.27 (suppl_2), p.ii26-ii26 [Periódico revisado por pares]Oxford University PressTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
518 A multicenter prospective single-arm study to assess the predictive biomarkers of PSK responder from the analysis of cytokine promoter gene polymorphisms in patients with stage II or III colorectal cancerNishimura, T ; Yoshino, S ; Sakata, K ; Furuya, T ; Inoue, K ; Saeki, T ; Takemoto, K ; Etoh, R ; Kawaoka, T ; Hasegawa, H ; Kondo, H ; Araki, A ; Kudo, A ; Hashimoto, K ; Uchiyama, T ; Yamamoto, T ; Inoue, Y ; Okayama, N ; Hazama, S ; Nagano, HEuropean journal of cancer (1990), 2015-09, Vol.51, p.S109-S109 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study)Iguchi, H ; Suzuki, N ; Uesugi, K ; Tanaka, H ; Hirakawa, K ; Aruga, A ; Hatori, T ; Ishizaki, H ; Umeda, Y ; Fujiwara, T ; Shimada, M ; Ikemoto, T ; Yoshimatsu, K ; Shimizu, R ; Hayashi, H ; Sakata, K ; Yoshino, S ; Furukawa, H ; Hazama, S ; Oka, MEuropean journal of cancer (1990), 2015-09, Vol.51, p.S114-S114 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II studyKato, T. ; Muro, K. ; Yamaguchi, K. ; Bando, H. ; Hazama, S. ; Amagai, K. ; Baba, H. ; Denda, T. ; Shi, X. ; Fukase, K. ; Sakamoto, J. ; Mishima, H.Annals of oncology, 2012-04, Vol.23 (4), p.933-941 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |